Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area
Bolt Biotherapeutics trading under the ticker symbol BOLT on Nasdaq has been granted Orphan Drug Designation by the US Food and Drug Administration FDA for their drug BDC This designation is specifically for the treatment of gastric cancer which incl...
IDEAYA Biosciences a precision medicine oncology company listed on NASDAQ as IDYA has announced that the US Food and Drug Administration FDA has granted Fast Track designation for their developmental program involving IDE
Adcentrx Therapeutics a biotechnology company focused on advancing AntibodyDrug Conjugate ADC therapies for cancer and other lifethreatening diseases has announced a significant milestone with the initiation of patient dosing in the Phase ab clinical...
PharmaTher Holdings Ltd OTCQB PHRRF CSE PHRM a specialized pharmaceutical company with a focus on commercialization has received approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for KETARX
Taysha Gene Therapies Inc Nasdaq TSHA a clinicalstage biotechnology company specializing in gene therapies for monogenic diseases of the central nervous system CNS has reported the dosing of the second patient with TSHA in the REVEAL Phase adult tri...
MilliporeSigma the US and Canadabased Life Science division of Merck KGaA Darmstadt Germany has established itself as the pioneering CTDMO Contract Testing Development and Manufacturing Organization offering comprehensive services across all critical...
Biora Therapeutics Inc Nasdaq BIOR a biotechnology company specializing in innovative therapeutic delivery solutions has officially submitted its Investigational New Drug IND application to the US Food and Drug Administration FDA
AcuraStem a pioneering biotechnology firm dedicated to revolutionizing the development of treatments for neurodegenerative disorders has announced a significant licensing agreement with Takeda This partnership is intended to advance AcuraStems target...
Reviva Pharmaceuticals Holdings Inc NASDAQ RVPH has made a significant announcement regarding the successful conclusion of patient evaluations in its global pivotal Phase RECOVER trial which aims to assess the effectiveness of brilaroxazine as a tre...
bio Inc Nasdaq ETNB a clinicalstage biopharmaceutical company specializing in innovative therapies for liver and cardiometabolic diseases has achieved Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for pegozafermins...
